|1.||Kinsella, B Therese: 4 articles (06/2014 - 09/2005)|
|2.||Zou, Ming-Hui: 4 articles (06/2013 - 10/2005)|
|3.||Chakraborty, Raja: 3 articles (01/2014 - 01/2012)|
|4.||Chelikani, Prashen: 3 articles (01/2014 - 01/2012)|
|5.||Dakshinamurti, Shyamala: 3 articles (01/2014 - 01/2012)|
|6.||Zhao, Jing: 2 articles (01/2015 - 10/2013)|
|7.||Fu, Yi: 2 articles (01/2015 - 10/2013)|
|8.||Tai, Hsin-Hsiung: 2 articles (08/2014 - 01/2013)|
|9.||Li, Xiuling: 2 articles (08/2014 - 01/2013)|
|10.||Mulvaney, Eamon P: 2 articles (06/2014 - 04/2011)|
05/01/1990 - "We studied the effects of a new potent thromboxane A2 receptor antagonist as a protective measure in circulatory shock induced by splanchnic artery occlusion and reperfusion. "
08/01/1994 - "Protective effects of BAY U 3405, a thromboxane A2 receptor antagonist, in endotoxin shock."
01/01/1992 - "Protective effects of G 619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, in splanchnic artery occlusion shock."
05/01/1989 - "Protective effects of ONO 3708, a new thromboxane A2 receptor antagonist, during experimental endotoxin shock."
12/01/1994 - "Beneficial effects of BAY u3405, a novel thromboxane A2 receptor antagonist, in splanchnic artery occlusion shock."
06/01/2013 - "Thromboxane A2 receptor (TPr) has been reported to trigger vascular inflammation. "
02/01/2012 - "Gene coding thromboxane A2 receptor (TBXA2R), involved in chronic airway inflammation, has been associated with asthma in several genetic studies. "
12/01/2004 - "Thromboxane A2 receptor (TP) mediates bronchial smooth muscle cell (BSMC) contraction, airway hyperresponsiveness, and airway inflammation in patients with asthma. "
01/01/2008 - "The direct intratracheal instillation of PGD2 enhanced the eosinophilic inflammation in OVA-exposed animals, whereas pretreatment with a dual antagonist against the PGD2 receptor-(CRTH2) and the thromboxane A2 receptor, but not with a thromboxane A2 receptor-specific antagonist, nearly completely eliminated the dsRNA-induced worsening of airway inflammation and bronchial hyperresponsiveness. "
06/01/1999 - "Effect of AA-2414, a thromboxane A2 receptor antagonist, on airway inflammation in subjects with asthma."
05/01/1995 - "Measurements taken during active unstable angina but not those taken during inactive angina showed an increase number (p < 0.001), without changes in affinity, of platelet TxA2/PGH2 receptors, evaluated as the binding capacity of iodine 125-PTA-OH, a stable TxA2 analogue. "
06/01/1997 - "The efficacy of DTTX30, a combined thromboxane A2 receptor blocker-thromboxane synthetase inhibitor, in inhibiting recurrent coronary thrombosis was evaluated in vivo using a canine model of unstable angina pectoris. "
05/01/1995 - "The current study was designed to investigate the number and affinity of platelet thromboxane A2/prostaglandin H2 (TxA2/PGH2) receptors in patients with unstable angina and, if any, the role played by the increased thrombin formation that is a common finding in these patients. "
01/01/1990 - "To determine the density and affinity of platelet thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptors in patients with acute myocardial infarction and unstable angina pectoris, the maximum number of binding sites (Bmax) per platelet and the dissociation constant (Kd) of the TXA2/PGH2 receptor antagonist, [125I]-PTA-OH, was determined at equilibrium in washed platelets. "
11/01/1999 - "Effects of the thromboxane A2 receptor antagonist on platelet deposition and intimal hyperplasia after balloon injury."
01/01/1991 - "This study evaluated the efficacy of a prostacyclin analog, iloprost, and a thromboxane A2 receptor antagonist, daltroban, as inhibitors of experimental intimal hyperplasia. "
01/01/1991 - "Evaluation of a prostacyclin analog, iloprost, and a thromboxane A2 receptor antagonist, daltroban, in experimental intimal hyperplasia."
01/01/1997 - "Furthermore, the reduction in arachidonic acid-induced sudden death in nonresponders indicates that the vascular smooth muscle thromboxane A2 receptor mediates this effect."
12/01/1991 - "Protective effects of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e]oxepine-2-carboxylate monohydrate against 9,11-dideoxy- 9 alpha, 11 alpha-epoxymethano-prostaglandin F2 alpha-induced sudden death in guinea-pigs and rats."
|2.||Aspirin (Acetylsalicylic Acid)
|8.||Arachidonic Acid (Vitamin F)